A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.

Published on Jun 1, 2021in European Urology Oncology
· DOI :10.1016/J.EUO.2020.12.008
Anthony Simon Bates2
Estimated H-index: 2
(ARI: Aberdeen Royal Infirmary),
Jennifer Ayers2
Estimated H-index: 2
(ARI: Aberdeen Royal Infirmary)
+ 30 AuthorsThomas B. Lam42
Estimated H-index: 42
(ARI: Aberdeen Royal Infirmary)
Abstract Context The clinical effectiveness of focal therapy (FT) for localised prostate cancer (PCa) remains controversial. Objective To analyse the evidence base for primary FT for localised PCa via a systematic review (SR) to formulate clinical practice recommendations. Evidence acquisition A protocol-driven, PRISMA-adhering SR comparing primary FT (sub-total, focal, hemi-gland, or partial ablation) versus standard options (active surveillance [AS], radical prostatectomy [RP], or external beam radiotherapy [EBRT]) was undertaken. Only comparative studies with ≥50 patients per arm were included. Primary outcomes included oncological, functional, and quality-of-life outcomes. Risk of bias (RoB) and confounding assessments were undertaken. Eligible SRs were reviewed and appraised (AMSTAR) and ongoing prospective comparative studies were summarised. Evidence synthesis Out of 1119 articles identified, four primary studies (1 randomised controlled trial [RCT] and 3 retrospective studies) recruiting 3961 patients and ten eligible SRs were identified. Only qualitative synthesis was possible owing to clinical heterogeneity. Overall, RoB and confounding were moderate to high. An RCT comparing vascular-targeted focal photodynamic therapy (PDT) with AS found a significantly lower rate of treatment failure at 2 yr with PDT. There were no differences in functional outcomes, although PDT was associated with worse transient adverse events. However, the external validity of the study was contentious. A retrospective study comparing focal HIFU with robotic RP found no significant differences in treatment failure at 3 yr, with focal HIFU having better continence and erectile function recovery. Two retrospective cohort studies using Surveillance, Epidemiology and End Results data compared focal laser ablation (FLA) against RP and EBRT, reporting significantly worse oncological outcomes for FLA. The overall data quality and applicability of the primary studies were limited because of clinical heterogeneity, RoB and confounding, lack of long-term data, inappropriate outcome measures, and poor external validity. Virtually all the SRs identified concluded that there was insufficient high-certainty evidence to make definitive conclusions regarding the clinical effectiveness of FT, with the majority of SRs judged to have a low or critically low confidence rating. Eight ongoing prospective comparative studies were identified. Ways of improving the evidence base are discussed. Conclusions The certainty of the evidence regarding the comparative effectiveness of FT as a primary treatment for localised PCa was low, with significant uncertainties. Until higher-certainty evidence emerges from robust prospective comparative studies measuring clinically meaningful outcomes at long-term time points, FT should ideally be performed within clinical trials or well-designed prospective cohort studies. Patient summary We examined the literature to determine the effectiveness of prostate-targeted treatment compared with standard treatments for untreated localised prostate cancer. There was no strong evidence showing that focal treatment compares favourably with standard treatments; consequently, focal treatment is not recommended for routine standard practice.
📖 Papers frequently viewed together
14 Citations
13 Citations
1 Citations
#1Ushasi Naha (UIC: University of Illinois at Chicago)H-Index: 2
#2Stephen J. Freedland (Durham University)H-Index: 96
Last. Daniel M. Moreira (UIC: University of Illinois at Chicago)H-Index: 32
view all 4 authors...
Active surveillance (AS) provides appropriate prostate cancer (PCa)-specific survival while minimizing morbidity, but underlying worry of PCa can generate anxiety. The aim of the study is to evaluate anxiety levels in men on AS and how anxiety relates to disease characteristics and treatment decision-making. A retrospective analysis was conducted using all 302 subjects from the Reduction by Dutasteride of clinical progression Events in Expectant Management (REDEEM) study. Prostate biopsies were ...
1 CitationsSource
#2Bradford J. WoodH-Index: 86
Last. Thomas J. Polascik (Duke University)H-Index: 69
view all 7 authors...
PURPOSE: To review the current evidence regarding protocols and outcomes of image-guided focal therapy (FT) for prostate cancer (PCa). METHODS: A literature search of the latest published studies assessing primary FT for PCa was carried out in Medline and Cochrane library databases followed by a critical review. FT modalities, follow-up strategies, and oncological and toxicity outcomes were summarized and discussed in this review. RESULTS: Twenty-four studies with six different sources of energy...
3 CitationsSource
#1Amir H. LebastchiH-Index: 15
#2Arvin K. George (UM: University of Michigan)H-Index: 29
Last. Ardeshir R. Rastinehad (Mount Sinai Health System)H-Index: 4
view all 21 authors...
Abstract Background Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by urologists and radiologists as an option for the management of localized prostate cancer. Objective To find consensus on a standardized nomenclature and to define a follow-up guideline after FT and PGA for localized prostate cancer in clinical practice. Design, setting, and participants A review of the literature identified controversial topics in the field of FT. Online questionnaires were distributed...
22 CitationsSource
#1Xie Yunhu (Inner Mongolia Normal University)
#2Xiao-hong Dang (Inner Mongolia Agricultural University)H-Index: 1
Last. Rui-ping Zhou (Inner Mongolia Normal University)H-Index: 2
view all 10 authors...
Wind and sand control features are important tools for limiting desertification. Sand barriers are one of the oldest engineering measures used to reduce wind-sand hazards. Their efficacy and exact mechanism by which they work has remained a topic of scientific debate however. Sediment grain-size distributions can help constrain their utility and function. This research analyzed sediment grain size distributions in samples collected from areas around six different types of sand barriers installed...
17 CitationsSource
#1Francesco ZiglioliH-Index: 7
#2Marco BaciarelloH-Index: 13
Last. Umberto MaestroniH-Index: 13
view all 8 authors...
Abstract Introduction Prostate cancer is considered one of the most important health problems. Due to the increased number of diagnosed patients and the inability to distinguish aggressive tumors, minimally-invasive procedures have become increasingly interesting. High-intensity focused ultrasound (HIFU) is an alternative option to radical surgery to treat prostate cancer. To date, however, data on side effects and comorbidities of this technique are still not conclusive. Methods and results We ...
2 CitationsSource
#1Xianghong Zhou (Sichuan University)H-Index: 1
#2Kun Jin (Sichuan University)H-Index: 4
Last. Qiang Wei (Sichuan University)H-Index: 28
view all 10 authors...
At present, focal laser ablation (FLA) as a new PCa local treatment has attracted attention. We aim at comparing the survival outcomes between radiotherapy (RT) and FLA to reveal whether FLA can be used as an alternative to RT for patients with low and intermediate-risk localized PCa.We conducted analyses with data from the SEER database (2004–2015). Propensity score matching and instrumental variate (IV) were used to reduce the influence of bias and unmeasured confounders maximally.In the adjus...
1 CitationsSource
#1Jeffrey J. Tosoian (UM: University of Michigan)H-Index: 29
#2Mufaddal Mamawala (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 13
Last. Michael A. Gorin (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 34
view all 8 authors...
Abstract Background Active surveillance (AS) is the preferred management option for most men with grade group (GG) 1 prostate cancer (PCa). Questions persist regarding long-term outcomes and the optimal approach to AS. Objective To determine survival and metastatic outcomes in AS patients. Secondary objectives were to measure the cumulative incidence and association of patient-level factors on biopsy grade reclassification. Design, setting, and participants A prospective, active, open-enrollment...
55 CitationsSource
#1Catherine Lovegrove (Imperial College London)H-Index: 6
#2Max PetersH-Index: 13
Last. Suks Minhas (Imperial College London)H-Index: 29
view all 20 authors...
OBJECTIVES: To assess change in functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) treatment compared with outcomes after one focal HIFU treatment. PATIENTS AND METHODS: In this multicentre study (2005-2016), 821 men underwent focal HIFU for localized non-metastatic prostate cancer. The patient-reported outcome measures of International Prostate Symptom Score (IPSS), pad usage and erectile function (EF) score were prospectively collected for up to 3 years. To ...
6 CitationsSource
#1Deepika Reddy (Imperial College London)H-Index: 3
#2Taimur T. Shah (Imperial College London)H-Index: 14
Last. Hashim U. Ahmed (Imperial College London)H-Index: 62
view all 14 authors...
Abstract Introduction Focal therapy (FT) targets individual areas of cancer within the prostate, providing oncological control with minimal side-effects. Early evidence demonstrates encouraging short-medium-term outcomes. With no randomized controlled trials (RCT) comparing FT to radical therapies, Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (CHRONOS) will compare the cancer control of these two strategies. Patients and methods CHRONOS is a parallel phase II RCT ...
8 CitationsSource
#1David E. Neal (University of Oxford)H-Index: 111
#2Chris Metcalfe (UoB: University of Bristol)H-Index: 61
Last. Tracy E RobertsH-Index: 40
view all 282 authors...
Abstract Background The ProtecT trial reported intention-to-treat analysis of men with localised prostate cancer randomly allocated to active monitoring (AM), radical prostatectomy, and external beam radiotherapy. Objective To report outcomes according to treatment received in men in randomised and treatment choice cohorts. Design, setting, and participants This study focuses on secondary care. Men with clinically localised prostate cancer at one of nine UK centres were invited to participate in...
48 CitationsSource
Cited By2
#1Arnas Rakauskas (UNIL: University of Lausanne)
#2Giancarlo Marra (UNITO: University of Turin)H-Index: 13
view all 15 authors...
#1Ankeet Shah (Duke University)H-Index: 4
#2Thomas J. Polascik (Duke University)H-Index: 69